pharmaceuticals

Everything you need to know about Jubilant Pharmova

● Oct 6, 2022

About Company and its Outlook:  Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals,...

Jubilant Pharmova reports dip in its net profit by 71% for Q1FY23

● Oct 3, 2022

Jubilant Pharmova reported total income of INR 1,452 crores during the period ended June 30, 2022 as compared to INR...

Panacea Biotech Q1FY23 Net profit soars by 2%

● Sep 30, 2022

Panacea Biotec reported total income of INR 111 crores during the period ended June 30, 2022 as compared to INR...

Balaxi Pharmaceuticals Ltd Q1 FY23 Earnings Conference Call Insights

● Sep 15, 2022

Key highlights from Balaxi Pharmaceuticals Ltd (BALAXI) Q1 FY23 Earnings Concall Q&A Highlights: [00:06:25] Archana Gude with IDBI asked about...

SMS Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights

● Sep 7, 2022

Key highlights from SMS Pharmaceuticals Limited (SMSPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: Atul Kothari from Progwell Securities asked about...

Top 5 Stocks with 200% Profit Growth in 2022

● Sep 3, 2022

1. India Cements Ltd India Cements Ltd is a leading cement manufacturing company based in Chennai. It was founded in...

Gufic Biosciences Limited Q1 FY23 Earnings Conference Call Insights

● Sep 2, 2022

Key highlights from Gufic Biosciences Limited (GUFICBIO) Q1 FY23 Earnings Concall Q&A Highlights: Girish Gulati asked about pancreatic cancer update...

Aurobindo Pharma Limited Q1 FY23 Earnings Conference Call Insights

● Sep 2, 2022

Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: [00:08:34] Prakash Agarwal of Axis Capital asked...

Shilpa Medicare Ltd Q1 FY23 Earnings Conference Call Insights

● Aug 31, 2022

Key highlights from Shilpa Medicare Ltd (SHILPAMED) Q1 FY23 Earnings Concall Q&A Highlights: Vineet Gala of Monarch Networth asked about...

Marksans Pharma Limited Q1 FY23 Earnings Conference Call Insights

● Aug 30, 2022

Key highlights from Marksans Pharma Limited (MARKSANS) Q1 FY23 Earnings Concall Management Update: MARKSANS said it aims to increase its...